- Home
- CISS vs SCNI Comparison
CISS vs SCNI Comparison
Compare CISS & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- SCNI
- Stock Information
- Founded
- CISS 2022
- SCNI 2003
- Country
- CISS Greece
- SCNI Israel
- Employees
- CISS N/A
- SCNI N/A
- Industry
- CISS Marine Transportation
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CISS Consumer Discretionary
- SCNI Health Care
- Exchange
- CISS Nasdaq
- SCNI Nasdaq
- Market Cap
- CISS 2.5M
- SCNI 2.0M
- IPO Year
- CISS N/A
- SCNI N/A
- Fundamental
- Price
- CISS $3.03
- SCNI $1.60
- Analyst Decision
- CISS
- SCNI
- Analyst Count
- CISS 0
- SCNI 0
- Target Price
- CISS N/A
- SCNI N/A
- AVG Volume (30 Days)
- CISS 257.4K
- SCNI 3.2M
- Earning Date
- CISS 09-02-2025
- SCNI 09-02-2025
- Dividend Yield
- CISS N/A
- SCNI N/A
- EPS Growth
- CISS N/A
- SCNI N/A
- EPS
- CISS N/A
- SCNI N/A
- Revenue
- CISS $38,174,754.00
- SCNI $658,000.00
- Revenue This Year
- CISS N/A
- SCNI N/A
- Revenue Next Year
- CISS N/A
- SCNI N/A
- P/E Ratio
- CISS N/A
- SCNI N/A
- Revenue Growth
- CISS N/A
- SCNI N/A
- 52 Week Low
- CISS $2.85
- SCNI $1.40
- 52 Week High
- CISS $22.80
- SCNI $6.18
- Technical
- Relative Strength Index (RSI)
- CISS 38.84
- SCNI 43.57
- Support Level
- CISS $2.88
- SCNI $1.46
- Resistance Level
- CISS $3.80
- SCNI $1.79
- Average True Range (ATR)
- CISS 0.27
- SCNI 0.16
- MACD
- CISS -0.01
- SCNI 0.03
- Stochastic Oscillator
- CISS 16.30
- SCNI 32.73
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.